Publications
Print PDF
FDA's Abilify Smack-Down Boosts Imitator Drugs
October 9, 2015
Jeff Overley
Law360

Axinn Partner Chad Landmon was quoted in the Law360 article, “FDA's Abilify Smack-Down Boosts Imitator Drugs.”

Click here to read the article. A subscription is required.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.